🟢 Beam Therapeutics Inc is trading 4.3% up today on broader risk-on sentiment and a modest rebound

Beam Therapeutics Inc is trading 4.3% up at $30.29 in pre-market, modestly rebounding from its recent pullback as part of a broader market rally.

• The move reflects a risk-on environment driven by improved geopolitical sentiment and lower oil prices, which have increased investor appetite for growth and biotech stocks.
• U.S. equity futures and major indices are trading notably higher, providing a supportive backdrop for the sector.
• No company-specific catalysts, such as earnings, FDA decisions, or major analyst calls, have been reported for June 15, 2026.